These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35602)

  • 21. Behavioral correlates of dopaminergic supersensitivity.
    Iversen SD; Creese I
    Adv Neurol; 1975; 9():81-92. PubMed ID: 1170717
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of dopamine receptor stimulants on locomotor activity and cyclic AMP levels in the rat striatum.
    Elkhawad AO; Munday KA; Poat JA; Woodruff GN
    Br J Pharmacol; 1975 Mar; 53(3):456P-457P. PubMed ID: 165849
    [No Abstract]   [Full Text] [Related]  

  • 23. On the cyclic nucleotides involvement in rat striatal function.
    Carenzi A; Govoni S; Spano PF; Trabucchi M
    Pharmacol Res Commun; 1976 Oct; 8(5):519-24. PubMed ID: 194261
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative dopaminergic and muscarinic antagonist activity of clozapine and haloperidol.
    Sethy VH; Ellerbrock BR; Wu H
    Life Sci; 1996; 58(7):585-90. PubMed ID: 8632711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of apomorphine, amantadine and dimethylaminoadamantane on the level of cyclic AMP in the rat striatum.
    Janiec W; Piekarska T; Szczypior M; Misterkiewicz E
    Pol J Pharmacol Pharm; 1977; 29(2):93-9. PubMed ID: 193093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
    Randrup A
    Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3',5;-adenosine monophosphate concentrations of rat striatum.
    Gerhards HJ; Carenzi A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(1):49-63. PubMed ID: 4375258
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuroleptic drugs and their action on different neuronal pathways.
    Ungerstedt U; Herrera-Marschitz M; Forster C
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the mechanism of the decrease in cerebellar cyclic GMP content elicited by opiate receptor agonists.
    Biggio G; Guidotti A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):117-21. PubMed ID: 189228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LY83583: an agent that lowers intracellular levels of cyclic guanosine 3',5'-monophosphate.
    Schmidt MJ; Sawyer BD; Truex LL; Marshall WS; Fleisch JH
    J Pharmacol Exp Ther; 1985 Mar; 232(3):764-9. PubMed ID: 2857787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action of opiates, antipsychotics, amphetamine and apomorphine on dopamine receptors in rat striatum: in vivo changes of 3',5'-cyclic AMP content and acetylcholine turnover rate.
    Carenzi A; Cheney DL; Costa E; Guidotti A; Racagni G
    Neuropharmacology; 1975 Dec; 14(12):927-39. PubMed ID: 3748
    [No Abstract]   [Full Text] [Related]  

  • 32. Proceedings: Amphetamine and apomorphine responses in the rat after lesion of mesolimbic or striatal dopamine neurones.
    Iversen SD; Kelly PH; Miller RJ; Seviour P
    Br J Pharmacol; 1975 Jun; 54(2):244P. PubMed ID: 1148532
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of dopamine-like compounds on stereotypy and locomotor activity in atropinized rats.
    Grabowska M
    Arch Immunol Ther Exp (Warsz); 1975; 23(6):753-61. PubMed ID: 1241267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D(2) receptor activation is critical but not the expression of the unconditioned response.
    Dias FR; Carey RJ; Carrera MP
    Brain Res; 2006 Apr; 1083(1):85-95. PubMed ID: 16530737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of acute and chronic ethanol administration and withdrawal on adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate levels in the rat brain.
    Volicer L; Hurter BP
    J Pharmacol Exp Ther; 1977 Feb; 200(2):298-305. PubMed ID: 190377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCK modulation of cerebellar afferents: dopaminergic involvement.
    Wood PL
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):513-8. PubMed ID: 2546180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deuterated halothane--anesthetic potency, anticonvulsant activity, and effect on cerebellar cyclic guanosine 3',5'-monophosphate.
    Vulliemoz Y; Triner L; Verosky M; Hamm MW; Krishna G
    Anesth Analg; 1984 May; 63(5):495-8. PubMed ID: 6324614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apomorphine as an antagonist of the dopamine response from the nucleus accumbens.
    Costall B; Naylor RJ
    J Pharm Pharmacol; 1976 Jul; 28(7):592-5. PubMed ID: 8619
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies.
    Martres MP; Costentin J; Baudry M; Marcais H; Protais P; Schwartz JC
    Brain Res; 1977 Nov; 136(2):319-37. PubMed ID: 922486
    [No Abstract]   [Full Text] [Related]  

  • 40. Lithium antagonism of ethanol-induced depletion of cerebellar guanosine-3',5'-cyclic monophosphate and stimulation of striatal dopamine release.
    Hunt WA; Goldman ME
    J Stud Alcohol; 1979 May; 40(5):401-7. PubMed ID: 224268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.